(Q69892013)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3888433%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

title

A randomised trial of tamoxifen versus tamoxifen with aminoglutethimide in post-menopausal women with advanced breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3888433%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference

1 reference

R Milsted

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3888433%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

T Habeshaw

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3888433%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

S Kaye

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3888433%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

G Sangster

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3888433%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

F Macbeth

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3888433%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

J Campbell-Ferguson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3888433%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

D Smith

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3888433%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

K Calman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3888433%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

publication date

1 January 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3888433%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

6 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3888433%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3888433%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3888433%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

page(s)

272-273

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3888433%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00258132

6 October 2019

exact match

0 references

cites work

Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma

1 reference

12 December 2020

Tamoxifen and aminoglutethimide in advanced breast cancer

1 reference

12 December 2020

Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.

1 reference

12 December 2020

Tamoxifen in advanced breast cancer

1 reference

12 December 2020

Aminoglutethimide in the treatment of advanced postmenopausal breast cancer

1 reference

12 December 2020